Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study.

Background/Aims The frequency and details of nonalcoholic fatty liver disease (NAFLD) complications in patients with inflammatory bowel disease (IBD) remain unclear. This study aimed to clarify characteristics of NAFLD in patients with IBD. Methods We retrospectively identified and enrolled patients with IBD diagnosed with or without NAFLD by undergoing abdominal computed tomography (CT) at our institution between 2005 and 2020. The primary endpoint was the complication rate of NAFLD in patients with IBD. Secondary endpoints were the clinical characteristics of nonobese patients with IBD and comorbid NAFLD and their association with nutritional and inflammatory parameters. Results Twenty-one (21.9%) of 96 eligible patients with IBD also had NAFLD. In nonobese patients (defined as patients with a body mass index <25 kg/m2), C-reactive protein (CRP; P<0.001) and alanine aminotransferase (P=0.018) levels were higher and the albumin level (P=0.005) and prognostic nutritional index (PNI; P=0.002) values were lower in patients with NAFLD than in those without NAFLD. The PNI value was positively correlated (P<0.001) and the CRP level was negatively correlated (P=0.001) with the hepatosplenic ratio. However, in the NAFLD combined group, PNI (P<0.05) and CRP values (P<0.001) were improved over time after CT imaging by continuing IBD treatment. Conclusions Worsening nutritional and inflammatory status in IBD patients is associated with complications of NAFLD. Diagnosis of NAFLD in IBD patients using CT imaging might be useful not only for early detection of NAFLD but also in assessing the need for therapeutic intervention for IBD.

[1]  P. Gow,et al.  Moving computed tomography–based quantification of muscle mass to the mainstream: Validation of a web‐based platform to calculate skeletal muscle index in cirrhosis , 2022, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  J. Vaqué,et al.  Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  S. Gitto,et al.  The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease , 2021, Nutrients.

[4]  Z. Younossi,et al.  Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD , 2020, Hepatology.

[5]  A. Milinkovic,et al.  P140 Factors associated with development of NAFLD in patients with inflammatory bowel disease: a 5-year retrospective study on 225 patients , 2020 .

[6]  E. Hashimoto,et al.  Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index , 2020, Gut and liver.

[7]  K. Choi,et al.  Sarcopenia and fatty liver disease , 2019, Hepatology International.

[8]  J. Helzberg,et al.  Prevalence of non-alcoholic fatty liver disease on computed tomography in patients with inflammatory bowel disease visiting an emergency department , 2019, Annals of gastroenterology.

[9]  Louis Mullie,et al.  CoreSlicer: a web toolkit for analytic morphomics , 2019, BMC Medical Imaging.

[10]  B. Hamm,et al.  Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study , 2018, PloS one.

[11]  A. Diehl,et al.  Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis , 2017, The New England journal of medicine.

[12]  Vincent Wai-Sun Wong,et al.  New trends on obesity and NAFLD in Asia. , 2017, Journal of hepatology.

[13]  K. Chayama,et al.  Significance of non‐alcoholic fatty liver disease in Crohn's disease: A retrospective cohort study , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[14]  Wen-Chung Yu,et al.  Prognostic Nutritional Index and the Risk of Mortality in Patients With Acute Heart Failure , 2017, Journal of the American Heart Association.

[15]  G. Sebastiani,et al.  Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article , 2016, World journal of gastroenterology.

[16]  K. Moriya,et al.  Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  A. Bitton,et al.  Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease , 2016, Inflammatory bowel diseases.

[18]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[19]  Kyungdo Han,et al.  Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey. , 2016, Hepatobiliary & pancreatic diseases international : HBPD INT.

[20]  V. Wong,et al.  Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy , 2015, The American Journal of Gastroenterology.

[21]  T. Saibara,et al.  Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis , 2015, Journal of Gastroenterology.

[22]  J. Helzberg,et al.  NAFLD Appears to Be the Most Common Liver Disease in IBD Patients; IBD is Likely a Risk Factor for NAFLD: 494 , 2014 .

[23]  A. Ford,et al.  Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease , 2014, Alimentary pharmacology & therapeutics.

[24]  A. Craxì,et al.  Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey , 2014, Clinical medicine insights. Gastroenterology.

[25]  Shuling Chen,et al.  The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis , 2014, Journal of Cancer Research and Clinical Oncology.

[26]  T. Macdonald,et al.  The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis , 2012, Current opinion in gastroenterology.

[27]  T. Saibara,et al.  Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study , 2012, Journal of Gastroenterology.

[28]  C. Mcgowan,et al.  Changing shape of disease: Nonalcoholic fatty liver disease in Crohn's disease—A case series and review of the literature , 2012, Inflammatory bowel diseases.

[29]  R. Bataller,et al.  Alcoholic liver disease: pathogenesis and new therapeutic targets. , 2011, Gastroenterology.

[30]  A. Román,et al.  Comorbidity in inflammatory bowel disease. , 2011, World journal of gastroenterology.

[31]  M. Krstic,et al.  Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. , 2010, European journal of internal medicine.

[32]  K. Das,et al.  Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease , 2010, Hepatology.

[33]  L. Katsnelson,et al.  Interobserver and intraobserver variability in the sonographic assessment of fatty liver. , 2007, AJR. American journal of roentgenology.

[34]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[35]  J. Talwalkar,et al.  Diagnostic evaluation of nonalcoholic fatty liver disease. , 2006, Journal of clinical gastroenterology.

[36]  D. Kelly Intestinal failure-associated liver disease: what do we know today? , 2006 .

[37]  Matthias Pirlich,et al.  Prevalence of Malnutrition in Hospitalized Medical Patients: Impact of Underlying Disease , 2003, Digestive Diseases.

[38]  M. Gassull Nutrition and Inflammatory Bowel Disease: Its Relation to Pathophysiology, Outcome and Therapy , 2003, Digestive Diseases.

[39]  S. Morgan,et al.  Nutritional considerations in osteoporosis , 2003, Iowa medicine : journal of the Iowa Medical Society.

[40]  G. Porro,et al.  Sonographic Prevalence of Liver Steatosis and Biliary Tract Stones in Patients with Inflammatory Bowel Disease: Study of 511 Subjects at a Single Center , 2003, Journal of clinical gastroenterology.

[41]  J. Dixon,et al.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.

[42]  C. Fiocchi Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[43]  E. Oda New criteria for 'obesity disease' in Japan. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[44]  Tetsuji Sato,et al.  The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. , 2006, Annals of internal medicine.

[45]  Eiji Oda,et al.  New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[46]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[47]  E. Rosato,et al.  Prognostic nutritional index in gastrointestinal surgery. , 1980, American journal of surgery.